BRCA2 and prostate cancer: BRCA2 knockdown by siRNA or shRNA in C4-2 and DU145 prostate cancer cells instead increased apoptosis induced by 6-TG or the PARP inhibitor olaparib but not by PTX (Figure 5D and Figure 6A,C and Supplementary Figure S1).